Pharmaceuticals giant to launch SA’s first biotech manufacturing facility

Global pharmaceutical company Cipla announced in July that its proposed biotech subsidiary, Cipla BioTec South Africa (CBSA) will invest just over R1.3-billion into the country's first biotech manufacturing facility, used for the production of biosimilars, and located in KwaZulu-Natal. Cipla’s South African subsidiary Cipla Medpro – the third largest pharmaceuticals manufacturer in the country – and the biotechnology company will be focused on the manufacturing of affordable and accessible biopharmaceuticals.